Assessment of heart rate variability in participants with chronic obstructive pulmonary disease

Lalitha Surulichamy; Anandhalakshmi Swaminathan; Kanimozhi Sadasivam; Saravanan Ayyavoo

doi:10.5455/njppp.2017.7.0720605082016

2024, Vol: 14, Issue: 10

14 / 10Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

NJPPP Manuscript Submission Form

« Previous Article

Original Research
Online Published: 17 Aug 2016

Natl J Physiol Pharm Pharmacol. 2017; 7(1): 85-89

doi: 10.5455/njppp.2017.7.0720605082016

Assessment of heart rate variability in participants with chronic obstructive pulmonary disease

Lalitha Surulichamy, Anandhalakshmi Swaminathan, Kanimozhi Sadasivam, Saravanan Ayyavoo.

Cited By:1

Abstract
Background: Chronic obstructive pulmonary disease (COPD) is one of the main causes of morbidity and mortality worldwide. COPD kills half a million people in India every year, more than those who die due to tuberculosis, malaria, or Acquired immune deficiency syndrome, and 30 million people suffer with COPD in India.[1] The hypoxemia due to COPD might be associated with autonomic dysfunction which could be evaluated with heart rate variability (HRV).

Aims and Objective: To determine the HRV in patients with COPD and to compare with normal individuals.

Materials and Methods: This cross-sectional study was carried out in 30 COPD patients attending the Department of Pulmonology, SRM Medical College Hospital and Research Centre and 30 age and sex-matched healthy individuals as a control group. A detailed history from the participants, such as weight and height, was obtained, and HRV parameters such as mean RR, mean HR, successive normal sinus RR intervals >50 ms (NN50), the percentage of successive normal sinus RR intervals >50 ms (pNN50), root mean square of successive heartbeat interval differences (rMSSDs), high frequency (HF), low frequency (LF), and LF/HF were estimated using physio-pac instrument.

Results: HRV parameters such as rMSSD, NN50, PNN50, LF, HF, and LF/HF ratio show significant differences between the COPD and control (P < 0.05), which indicates sympathovagal imbalance.

Conclusion: HRV analysis shows that COPD participants have an autonomic imbalance suggestive of an increased sympathetic tone or decreased parasympathetic tone. Sympathetic overactivity may lead to cardiovascular disease development in patients with COPD.

Key words: Autonomic Dysfunction; Chronic Obstructive Pulmonary Disease; Heart Rate Variability

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Lalitha Surulichamy Articles by Anandhalakshmi Swaminathan Articles by Kanimozhi Sadasivam Articles by Saravanan Ayyavoo
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Lalitha Surulichamy, Anandhalakshmi Swaminathan, Kanimozhi Sadasivam, Saravanan Ayyavoo. Assessment of heart rate variability in participants with chronic obstructive pulmonary disease. Natl J Physiol Pharm Pharmacol. 2017; 7(1): 85-89. doi:10.5455/njppp.2017.7.0720605082016

Web Style

Lalitha Surulichamy, Anandhalakshmi Swaminathan, Kanimozhi Sadasivam, Saravanan Ayyavoo. Assessment of heart rate variability in participants with chronic obstructive pulmonary disease. https://www.njppp.com/?mno=236504 [Access: November 01, 2024]. doi:10.5455/njppp.2017.7.0720605082016

AMA (American Medical Association) Style

Lalitha Surulichamy, Anandhalakshmi Swaminathan, Kanimozhi Sadasivam, Saravanan Ayyavoo. Assessment of heart rate variability in participants with chronic obstructive pulmonary disease. Natl J Physiol Pharm Pharmacol. 2017; 7(1): 85-89. doi:10.5455/njppp.2017.7.0720605082016

Vancouver/ICMJE Style

Lalitha Surulichamy, Anandhalakshmi Swaminathan, Kanimozhi Sadasivam, Saravanan Ayyavoo. Assessment of heart rate variability in participants with chronic obstructive pulmonary disease. Natl J Physiol Pharm Pharmacol. (2017), [cited November 01, 2024]; 7(1): 85-89. doi:10.5455/njppp.2017.7.0720605082016

Harvard Style

Lalitha Surulichamy, Anandhalakshmi Swaminathan, Kanimozhi Sadasivam, Saravanan Ayyavoo (2017) Assessment of heart rate variability in participants with chronic obstructive pulmonary disease. Natl J Physiol Pharm Pharmacol, 7 (1), 85-89. doi:10.5455/njppp.2017.7.0720605082016

Turabian Style

Lalitha Surulichamy, Anandhalakshmi Swaminathan, Kanimozhi Sadasivam, Saravanan Ayyavoo. 2017. Assessment of heart rate variability in participants with chronic obstructive pulmonary disease. National Journal of Physiology, Pharmacy and Pharmacology, 7 (1), 85-89. doi:10.5455/njppp.2017.7.0720605082016

Chicago Style

Lalitha Surulichamy, Anandhalakshmi Swaminathan, Kanimozhi Sadasivam, Saravanan Ayyavoo. "Assessment of heart rate variability in participants with chronic obstructive pulmonary disease." National Journal of Physiology, Pharmacy and Pharmacology 7 (2017), 85-89. doi:10.5455/njppp.2017.7.0720605082016

MLA (The Modern Language Association) Style

Lalitha Surulichamy, Anandhalakshmi Swaminathan, Kanimozhi Sadasivam, Saravanan Ayyavoo. "Assessment of heart rate variability in participants with chronic obstructive pulmonary disease." National Journal of Physiology, Pharmacy and Pharmacology 7.1 (2017), 85-89. Print. doi:10.5455/njppp.2017.7.0720605082016

APA (American Psychological Association) Style

Lalitha Surulichamy, Anandhalakshmi Swaminathan, Kanimozhi Sadasivam, Saravanan Ayyavoo (2017) Assessment of heart rate variability in participants with chronic obstructive pulmonary disease. National Journal of Physiology, Pharmacy and Pharmacology, 7 (1), 85-89. doi:10.5455/njppp.2017.7.0720605082016

Author Login Reviewer Login About Publisher Editorial Policies Editorial Review Policy Peer Review Policy Editorial & Peer Review Process Publication Ethics and Publication Malpractice Statement Conflict of Interest Policy Plagiarism Policy Protection of Research Participants (Statement On Human And Animal Rights)Corrections, Retractions & Expressions of Concern Self-Archiving Policies Digital Archiving & Preservation Policies Statement of Informed Consent Advertising Policy Terms of Use License Information Copyright Information

About National Journal of Physiology, Pharmacy and Pharmacology

Contact Information

How to cite this article